1. Home
  2. TRNS vs TBPH Comparison

TRNS vs TBPH Comparison

Compare TRNS & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRNS
  • TBPH
  • Stock Information
  • Founded
  • TRNS 1964
  • TBPH 2013
  • Country
  • TRNS United States
  • TBPH United States
  • Employees
  • TRNS N/A
  • TBPH N/A
  • Industry
  • TRNS Electrical Products
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRNS Industrials
  • TBPH Health Care
  • Exchange
  • TRNS Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • TRNS 661.7M
  • TBPH 699.0M
  • IPO Year
  • TRNS N/A
  • TBPH N/A
  • Fundamental
  • Price
  • TRNS $62.35
  • TBPH $14.75
  • Analyst Decision
  • TRNS Buy
  • TBPH Strong Buy
  • Analyst Count
  • TRNS 4
  • TBPH 4
  • Target Price
  • TRNS $108.67
  • TBPH $23.00
  • AVG Volume (30 Days)
  • TRNS 79.2K
  • TBPH 284.3K
  • Earning Date
  • TRNS 11-03-2025
  • TBPH 11-10-2025
  • Dividend Yield
  • TRNS N/A
  • TBPH N/A
  • EPS Growth
  • TRNS N/A
  • TBPH N/A
  • EPS
  • TRNS 1.21
  • TBPH 0.26
  • Revenue
  • TRNS $302,584,000.00
  • TBPH $77,205,000.00
  • Revenue This Year
  • TRNS $18.46
  • TBPH $79.82
  • Revenue Next Year
  • TRNS $7.49
  • TBPH N/A
  • P/E Ratio
  • TRNS $51.21
  • TBPH $59.49
  • Revenue Growth
  • TRNS 11.81
  • TBPH 24.49
  • 52 Week Low
  • TRNS $59.34
  • TBPH $7.90
  • 52 Week High
  • TRNS $112.94
  • TBPH $15.34
  • Technical
  • Relative Strength Index (RSI)
  • TRNS 29.67
  • TBPH 58.51
  • Support Level
  • TRNS $69.97
  • TBPH $14.11
  • Resistance Level
  • TRNS $80.34
  • TBPH $15.34
  • Average True Range (ATR)
  • TRNS 4.79
  • TBPH 0.42
  • MACD
  • TRNS -0.64
  • TBPH 0.06
  • Stochastic Oscillator
  • TRNS 14.14
  • TBPH 63.55

About TRNS Transcat Inc.

Transcat Inc is involved in providing calibration and laboratory instrument services and the distribution of test, measurement, and control instrumentation. The product and services portfolio of the company consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, and others. The firm has Service and Distribution operating segments. The company derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Extech, FLIR, Fluke, Keysight, Megger, and others.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: